[1] Julie S, John M, Federica B, et al. Cardiac troponin and its relationship to cardiovascular outcomes in community populations-a systematic review and meta-analysis[J]. Heart Lung Circ, 2016, 25(3):217-228.
[2] Moritz B, Evangelos G, Manuel K, et al. Prognostic value of high-sensitivity cardiac troponin T compared to riskscores in stable cardiovascular disease[J]. Am J Med, 2017, 130(5):572-582.
[3] Beata M, Stephane F, Maxime T, et al. Performance of highly sensitive cardiac troponin T assay to detect ischaemia at PET-CT in low-risk patients with acute coronary syndrome:a prospective observational study[J]. BMJ Open, 2017, 7(7):e014655.
[4] Park KC, Gaze DC, Collinson PO, et al. Cardiac troponins:from myocardial infarction to chronic disease[J]. Cardiovasc Res, 2017, 113(14):1708-1718.
[5] Greaser ML, Gergely J. Purification and properties of the components from troponin[J]. J Biol Chem, 1973, 248(6):2125-2133.
[6] Francesco B, Leonarda G, Davide M, et al. Comparison of diagnostic accuracy between three different rules of interpreting high sensitivity troponin T results[J]. Intern Emerg Med, 2012, 7(4):365-370.
[7] Li X, Luo R, Jiang R, et al. The prognostic use of serum concentrations of cardiac troponin-I, CK-MB and myoglobin in patients with idiopathic dilated cardiomyopathy[J]. Heart Lung, 2014, 43(3):219-224.
[8] Fred S, Yader S, Allan S, et al. Cardiac troponin assays:guide to understanding analytical characteristics and their impact on clinical care[J]. Clin Chem, 2017, 63(1):73-81.
[9] Kozinski M, Krintus M, Kubica J, et al. High-sensitivity cardiac troponin assays:from improved analytical performance to enhanced risk stratification[J]. Crit Rev Clin Lab Sci, 2017, 54(3):143-172.
[10] Sayadnik M, Shafiee A, Jenab Y, et al. Predictors of high sensitivity cardiac troponin T elevation in patients with acute paroxysmal supraventricular tachycardia and ischemic heart disease[J]. Tex Heart Inst J, 2017, 44(5):306-311.
[11] Bergenzaun L, Ohlin H, Gudmundsson P, et al. High-sensitive cardiac troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care[J]. BMC Anesthesiol, 2012, 12:25.
[12] Völkers M, Rohde D, Zelniker T, et al. High-sensitive troponin T increase after exercise in patients with pulmonary arterial hypertension[J]. BMC Pulm Med, 2013, 13:28.
[13] McEvoy JW, Chen Y, Nambi V, et al. High-sensitivity cardiac troponin T and risk of hypertension[J]. Circulation, 2015, 132(9):825-833.
[14] Sun L, Ji Y, Wang Y, et al. High-sensitive cardiac troponin T:a biomarker of left-ventricular diastolic dysfunction in hemodialysis patients[J]. J Nephrol, 2018, 31(6):967-973.
[15] Iqbal N, Wentworth B, Choudhary R, et al. Cardiac biomarkers:new tools for heart failure management[J]. Cardiovasc Diagn Ther, 2012, 2(2):147-164.
[16] Buiten MS, de Bie MK, Rotmans JI, et al. Serum cardiac troponin-I is superior to troponin-T as a marker for left ventricular dysfunction in clinically stable patients with end-stage renal disease[J]. PLoS One, 2015, 10(8):e0134245.
[17] Aimo A, Januzzi JL Jr, Vergaro G, et al. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate:a multimarker strategy for risk stratification in chronic heart failure[J]. Int J Cardiol, 2019, 277:166-172.
[18] Neukamm AM, Høiseth AD, Hagve TA, et al. High-sensitivity cardiac troponin T levels are increased in stable COPD[J]. Heart, 2013, 99(6):382-387.
[19] Turkmen S, Askin L, Uzel KE, et al. Association of high-sensitivity troponin T with left ventricular dysfunction in ankylosing spondylitis[J]. J Clin Rheumatol, 2018. doi:10.1097/RHU.0000000000000951.[Epub ahead of print]
[20] Cruz MA, Bremmer YA, Porter BO, et al. Cardiac troponin T and cardiac dysfunction in extremely low-birth-weight infants[J]. Pediatr Cardiol, 2006, 27(4):396-401.
[21] Valo M, Wons A, Moeller A, et al. Markers of myocardial ischemia in patients with obstructive sleep apnea and coronary artery disease[J]. Pulm Med, 2015, 2015:621450.
[22] Sandoval Y, Jaffe AS. Using high-sensitivity cardiac troponin T for acute cardiac care[J]. Am J Med, 2017, 130(12):1358-1365.e1.
[23] van der Linden N, Klinkenberg LJ, Bekers O, et al. Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population[J]. Medicine (Baltimore), 2016, 95(52):e5703.
[24] Aimo A, Januzzi JL Jr, Vergaro G, et al. Prognostic value of high-sensitivity troponin T in chronic heart failure:an individual patient data meta-analysis[J]. Circulation, 2018, 137(3):286-297.
[25] Hoff J, Wehner W, Nambi V. Troponin in cardiovascular disease prevention:updates and future direction[J]. Curr Atheroscler Rep, 2016, 18(3):12.
[26] Kopec M, Duma A, Helwani MA, et al. Improving prediction of postoperative myocardial infarction with high-sensitivity cardiac troponin T and NT-proBNP[J]. Anesth Analg, 2017, 124(2):398-405.
[27] Twerenbold R, Boeddinghaus J, Nestelberger T, et al. Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction[J]. J Am Coll Cardiol, 2017, 70(8):996-1012.
[28] Alquézar-Arbé A, Sionis A, Ordoñez-Llanos J, et al. Cardiac troponins:25 years on the stage and still improving their clinical value[J]. Crit Rev Clin Lab Sci, 2017, 54(7-8):551-571.
[29] Asrani P, Aly AM, Jiwani AK, et al. High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus[J]. J Perinatol, 2018, 38(11):1483-1489.
[30] Sherwood MW, Kristin Newby L. High-sensitivity troponin assays:evidence, indications, and reasonable use[J]. J Am Heart Assoc, 2014, 3(1):e000403.
[31] Chenevier-Gobeaux C, Bonnefoy-Cudraz É, Charpentier S, et al. High-sensitivity cardiac troponin assays:answers to frequently asked questions[J]. Arch Cardiovasc Dis, 2015, 108(2):132-149.
[32] Jehlicka P, Huml M, Rajdl D, et al. How to interpret elevated plasmatic level of high-sensitive troponin T in newborns and infants?[J]. Physiol Res, 2018, 67(2):191-195.
[33] Neves AL, Henriques-Coelho T, Leite-Moreira A, et al. Cardiac injury biomarkers in paediatric age:are we there yet?[J]. Heart Fail Rev, 2016, 21(6):771-781.
[34] Sandoval Y, Smith SW, Apple FS, et al. Present and future of cardiac troponin in clinical practice:a paradigm shift to high-sensitivity assays[J]. Am J Med, 2016, 129(4):354-365.
[35] Keselman B, Vergara M, Nyberg S, et al. A randomized cross-over study of the acute effects of running 5 km on glucose, insulin, metabolic rate, cortisol and troponin T[J]. PLoS One, 2017, 12(6):e0179401.
[36] Wang J, Ji W, Xu Z, et al. Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis[J]. Exp Ther Med, 2016, 11(1):154-156.
[37] Sadoh WE, Eregie CO, Nwaneri DU, et al. The diagnostic value of both troponin T and creatinine kinase isoenzyme (CK-MB) in detecting combined renal and myocardial injuries in asphyxiated infants[J]. PLoS One, 2014, 9(3):e91338.
[38] Correale M, Nunno L, Ieva R, et al. Troponin in newborns and pediatric patients[J]. Cardiovasc Hematol Agents Med Chem, 2009, 7(4):270-278.
[39] Kluckow M, Lemmers P. Hemodynamic assessment of the patent ductus arteriosus:beyond ultrasound[J]. Semin Fetal Neonatal Med, 2018, 23(4):239-244.
[40] Türker G, Babaoğlu K, Gökalp AS, et al. Cord blood cardiac troponin I as an early predictor of short-term outcome in perinatal hypoxia[J]. Biol Neonate, 2004, 86(2):131-137.
[41] Neukamm A, Einvik G, Didrik Høiseth A, et al. The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients[J]. BMC Pulm Med, 2016, 16(1):164.